The present study results support the hypothesis that both NT-pro BNP and hs-TnI are highly associated with 30-day mortality in noncritically ill COVID-19 hospitalized patients, consistent throughout successive pandemic waves involving different virus variants. This evidence concerns the gene NPPB and COVID-19.